CAS: 263707-16-0
![3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-](https://static.cymitquimica.com/products/IN/thumb/DA002SX8.jpg)
3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-
CAS:263707-16-0
Fórmula:
C16H15ClN4O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
330.7689
Ref: IN-DA002SX8
| 5mg | 35,00 € | ||
| 10mg | 52,00 € | ||
| 50mg | 93,00 € | ||
| 100mg | 107,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
ESI-09
CAS:263707-16-0
ESI-09 is a new-typel noncyclic nucleotide EPAC antagonist.The IC50 values of ESI-09 for EPAC1 and …
Fórmula:
C16H15ClN4O2
Pureza:
98.48% - 99.57%
Forma y color:
Solid
Peso molecular:
330.77
Ref: TM-T2244
| 2mg | 41,00 € | ||
| 5mg | 61,00 € | ||
| 10mg | 96,00 € | ||
| 25mg | 170,00 € | ||
| 50mg | 297,00 € | ||
| 100mg | 448,00 € | ||
| 1mL*10mM (DMSO) | 67,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
ESI 09
Producto controladoCAS:263707-16-0
Applications ESI 09 acts as an EPAC inhibitor, preventing EPAC-mediated insulin release form β-pancreatic cells. …
Fórmula:
C16H15ClN4O2
Forma y color:
Neat
Peso molecular:
330.769
Ref: TR-E658950
| 5mg | 142,00 € | ||
| 10mg | 236,00 € | ||
| 25mg | 446,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
Ref: 10-F547227
| 1mg | 32,00 € | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Enero de 2025
ESI-09
CAS:263707-16-0
ESI-09 is a novel drug candidate that has been shown to have synergistic effects with …
Fórmula:
C16H15ClN4O2
Pureza:
Min. 95%
Peso molecular:
330.77 g/mol
Ref: 3D-NKA70716
| 5mg | 385,00 € | ||
| 50mg | 1.535,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
